SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FLS, KNW, ELEV, CRKN on Behalf of Shareholders
NEW YORK, June 9, 2025 /PRNewswire/ — Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Flowserve Corporation (NYSE: FLS)'s merger with Chart Industries, Inc. Upon completion of the proposed transaction, Flowserve shareholders will own approximately 46.5% of the combined company. If you are a Flowserve shareholder, click here to learn more about your rights and options.
Know Labs, Inc. (NYSE American: KNW)'s sale to Goldeneye 1995 LLC. If you are a Know Labs shareholder, click here to learn more about your legal rights and options.
Elevation Oncology, Inc. (NASDAQ: ELEV)'s sale to Concentra Biosciences, LLC. Under the terms of the proposed transaction, Elevation shareholders will receive $0.36 in cash per share, plus one non-tradeable contingent value right representing the right to receive: (i) 100% of the closing net cash in excess of $26.4 million; and (ii) 80% of any net proceeds received within five years following closing from any disposition of EO-1022 that occurs within one year following closing. If you are an Elevation shareholder, click here to learn more about your rights and options.
Crown Electrokinetics Corp. (OTCMKTS: CRKN)'s sale to Crown EK Acquisition LLC for $3.15 per share. If you are a Crown Electrokinetics shareholder, click here to learn more about your rights and options.
Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders. We would handle the action on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.
Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:Halper Sadeh LLCDaniel Sadeh, Esq.Zachary Halper, Esq.(212) 763-0060sadeh@halpersadeh.comzhalper@halpersadeh.com https://www.halpersadeh.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Malaysian Reserve
an hour ago
- Malaysian Reserve
The Gross Law Firm Notifies Shareholders of Rocket Companies, Inc.(RKT) of a Class Action Lawsuit and an Upcoming Deadline
NEW YORK, June 9, 2025 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of Rocket Companies, Inc. (NYSE: RKT). Shareholders who purchased shares of RKT during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: CLASS PERIOD: March 29, 2021 to April 1, 2021 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (a) Rocket's gain on sale margins were contracting at the highest rate in two years as a result of increased competition among mortgage lenders, an unfavorable shift toward the lower margin Partner Network operating segment and compression in the price spread between the primary and secondary mortgage markets; (b) Rocket was engaged in a price war and battle for market share with its primary competitors in the wholesale market, which was further compressing margins in Rocket's Partner Network operating segment; (c) the adverse trends identified above were accelerating and, as a result, Rocket's gain on sale margins were on track to plummet at least 140 basis points in the first six months of 2021; (d) as a result of the above, the favorable market conditions that had preceded the Class Period and allowed Rocket to achieve historically high gain on sale margins had vanished as the Company's gain on sale margins had returned to levels not seen since the first quarter of 2019; (e) rather than remaining elevated due to surging demand, Rocket's Company-wide gain-on-sale margins had fallen materially below recent historical averages; and (f) as a result of the foregoing, defendants' positive statements about the Company's business operations and prospects were materially misleading and/or lacked a reasonable basis. DEADLINE: July 8, 2025 Shareholders should not delay in registering for this class action. Register your information here: NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of RKT during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is July 8, 2025. There is no cost or obligation to you to participate in this case. WHY GROSS LAW FIRM? The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a company lead to artificial inflation of the company's stock. Attorney advertising. Prior results do not guarantee similar outcomes. CONTACT:The Gross Law Firm15 West 38th Street, 12th floorNew York, NY, 10018Email: dg@ (646) 453-8903
Malaysian Reserve
an hour ago
- Malaysian Reserve
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OPOF, PRA, SWTX on Behalf of Shareholders
NEW YORK, June 9, 2025 /PRNewswire/ — Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Old Point Financial Corporation (NASDAQ: OPOF)'s sale to Hampton Roads based TowneBank. Under the terms of the agreement, Old Point shareholders will elect to receive either $41.00 in cash or 1.1400 shares of TowneBank common stock for each share of Old Point common stock. If you are an Old Point shareholder, click here to learn more about your rights and options. ProAssurance Corporation (NYSE: PRA)'s sale to The Doctors Company for $25.00 in cash per share. If you are a ProAssurance shareholder, click here to learn more about your rights and options. SpringWorks Therapeutics, Inc. (NASDAQ: SWTX)'s sale to Merck KGaA, Darmstadt, Germany for $47.00 per share in cash. If you are a SpringWorks shareholder, click here to learn more about your rights and options. Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders. We would handle the action on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses. Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@ or zhalper@ Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors. Attorney Advertising. Prior results do not guarantee a similar outcome. Contact Information:Halper Sadeh LLCDaniel Sadeh, Halper, Esq.(212) 763-0060sadeh@
New Straits Times
3 hours ago
- New Straits Times
Ispire Malaysia denies domestic vape sales, reaffirms export-only operations
KUALA LUMPUR: Nasdaq-listed Ispire Technology Inc's subsidiary, Ispire Malaysia Sdn Bhd, has clarified that all its vaporiser hardware manufacturing activities are strictly for export purposes, amid public scrutiny and recent reports suggesting otherwise. In a statement, Ispire emphasised it manufactures only semi-finished hardware devices and does not handle any nicotine or cannabis substances in Malaysia, with all production shipped abroad and not marketed or sold domestically. "We take this matter seriously and strictly adhere to all regulatory and licensing requirements, including the Control of Smoking Products for Public Health Act 2024 (Act 852). "These products do not contain any nicotine or cannabis – liquids or gels – and thus are not subject to the Health Ministry regulations under the Act 852," it said in a statement released this week. The clarification follows after recent articles reported Ispire had received Malaysia's first federal nicotine manufacturing licence in May. The development raised questions among lawmakers and the public, particularly due to vape product sales remain banned in several Malaysian states, including Johor. The Health Ministry (MOH) responded by confirming that the licence, issued by the Investment, Trade and Industry Ministry through the Malaysian Investment Development Authority, does not equate to permission to sell vape products locally. "The MOH has never approved any registration for the product for the local market. Any party intending to import, produce, or distribute smoking products locally must apply for product registration with the ministry." Ispire is involved in the research and development, design, sales, commercialisation, marketing, and distribution of vaping products and its own branded e-cigarettes. The interim licence granted to Ispire allows it to commence production of its products in Johor, which has banned vape sales since 2016. Ispire said its operations fully comply with all Malaysian laws and that any production involving nicotine would only occur upon approval from both state and federal regulators and will remain strictly for export. The company also highlighted its innovations in consumer protection technologies, including a blockchain-based age-gating system and geo-fencing technology to prevent underage or unauthorised usage. The Johor plant currently operates seven production lines, with plans to expand up to 80 lines following final regulatory approvals. The US$50 million investment into the Johor facility forms part of Ispire's strategic relocation of manufacturing from China to Malaysia to serve international markets such as the United States and the United Kingdom. "Our Malaysian operations focus exclusively on vaporiser hardware production, which is shipped empty for export only, with no nicotine or cannabis substances at any stage of the manufacturing process," it concluded.
